StockData
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc. (LFST) company profile

LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30249% above fair value
$14.48+0.40 (+2.84%)

Close on Nov 16, 2026Market cap $5.53BP/E 111.4Yield –

About LifeStance Health

Services-Health Services, SIC 8000

LifeStance Health Group, Inc. operates an outpatient mental healthcare platform providing in-person and virtual behavioral health services. The company offers a multidisciplinary range of care, including psychiatric evaluations, psychological and neuropsychological testing, and individual, family, and group therapy. Clinicians treat diverse mental health conditions such as anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Services are delivered through employed clinicians and affiliated practices, serving patients primarily through in-network commercial insurance plans, government healthcare programs, and self-pay arrangements.

The organization operates across 33 states and employs 8,040 licensed mental health clinicians through its subsidiaries and supported practices. LifeStance delivers services via physical centers as well as its digital platform, partnering with primary care physicians, specialists, and health systems to coordinate care. The company maintains its corporate headquarters in Scottsdale, Arizona.

Summary of the business section of LifeStance Health's latest annual report, written by StockData.

Company profile

Company

Legal name
LifeStance Health Group, Inc.
Headquarters
Scottsdale, AZ
Address
4800 N. Scottsdale Road, Suite 2500 85251
Phone
(602) 767-2100
Employees
10,961, Dec 31, 2025
Industry
Services-Health Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Seattle, Washington

Stock & identifiers

Ticker
LFST
Exchange
Nasdaq
IPO date
Jun 11, 2021
Shares outstanding
382M, Jul 29, 2026
Public float
$817.21M, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1845257
CUSIP
53228F101
ISIN
US53228F1012
FIGI
BBG01138DGZ7
Share class FIGI
BBG01138DHT2
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
David BourdonChief Executive Officer, Director1,248,247
Ryan PardoSee Remarks840,381
Lisa K. MillerChief Operating Officer251,904
Vukasin PaunovichChief Technology Officer205,379
Ann VaranakisChief People Officer413,881
Ryan McGroartySee Remarks772,235
Stephanie Carin EkenChief Medical Officer115,107
Ujjwal RamtekkarChief Medical Officer103,916
Pablo PantaleoniChief Digital Officer1,437,881
Kenneth A. BurdickDirector3,642,777
Teresa DeLucaDirector133,456
Safwan ShababDirector–
Lori GoltermannDirector35,492
Sarah PersonetteDirector92,512
Thurman JusticeDirector35,492
Robert BesslerDirector1,308,051
Eric P. PalmerDirector89,174
Darren M. BlackDirector23,310,115
Eric ShueyDirector961,544

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
David Bourdon
$6.65M$4.76M$3.26M$32$85
FY2025
Kenneth Burdick
$7.12M-$482.44K$3.26M$32$85
FY2024$10.20M$4.14M$4.17M$34$70
FY2023$14.83M$39.44M$2.54M$36$68
FY2022
Kenneth Burdick
$40.95M$27.35M$9.48M$23$65
FY2022
Michael KLester
$9.81M-$25.95M$9.48M$23$65

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
David Bourdon
Chief Executive Officer
$657.69K–$5.26M$716.07K$14.00K$6.65M+93%
Ryan McGroarty
Chief Financial Officer and Treasurer
$412.50K$570.00K$5.00M$518.93K$14.00K$6.52M–
Kenneth Burdick
Executive Chairperson; Former Chief Executive Officer
$284.62K–$6.47M$351.54K$14.00K$7.12M-30%
Ryan Pardo
Chief Legal Officer and Secretary
$350.00K–$2.02M$194.25K$14.00K$2.58M-1%
Ann Varanakis
Chief People Officer
$350.00K–$1.26M$194.25K$14.00K$1.82M+9%
Vaughn Paunovich
Chief Technology Officer
$251.83K–$1.33M$186.82K$8.63K$1.78M–
Pablo Pantaleoni
Former Chief Digital Officer
$232.12K–$2.91M–$455.25K$3.59M+30%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Jun 11, 2021
Offer price
$18.00
Securities offered
40,000,000
Gross proceeds
$720.00M
Exchange
Nasdaq
First trading day
Jun 10, 2021
First-day close
$21.90+21.7%
Lock-up ends (est.)
Dec 7, 2021

“See “Prospectus Summary—Implications of Being an Emerging Growth Company.” Per share Total Initial public offering price $ 18.00 $ 720,000,000 Underwriting discounts and commissions (1) $ 0.99 $ 39,600,000 Proceeds to us before expenses $ 17.01 $ 557,928,000 Proceeds to the selling stockholders $ 17.01 $ 122,472,000 (1) We have agreed to reimburse the underwriters for certain expenses in”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed approximately 10,961 employees through our subsidiaries and supported practices, of which 4,549 were directly employed through our subsidiaries and 6,412 were directly employed by our supported practices.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?